Dr. Elham Abbasi-Hafshejani, M.D.
What this data tells you about Dr. Abbasi-Hafshejani
Dr. Elham Abbasi-Hafshejani is a hematology & oncology in The Woodlands, TX, with 19 years in practice. Based on federal Medicare data, Dr. Abbasi-Hafshejani performed 101,056 Medicare services across 1,446 unique beneficiaries.
Between the years covered by Open Payments, Dr. Abbasi-Hafshejani received a total of $3,430 from 4 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abbasi-Hafshejani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 31,110 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 21,400 | $39 | $110 |
| Anti-nausea injection (ondansetron/Zofran) | 10,492 | $0 | $6 |
| Anti-nausea injection (fosaprepitant) | 8,850 | $0 | $4 |
| Dexamethasone injection (steroid) | 8,268 | $0 | $1 |
| Iron sucrose injection (Venofer) | 6,900 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 3,360 | $18 | $40 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 2,267 | $22 | $138 |
| Injection, magnesium sulfate, per 500 mg | 1,212 | $1 | $6 |
| Complete blood count (CBC) with differential | 1,037 | $7 | $34 |
| Office visit, established patient (30-39 min) | 962 | $91 | $182 |
| Infusion, normal saline solution , 1000 cc | 954 | $2 | $19 |
| Infusion into a vein for hydration, each additional hour | 911 | $10 | $66 |
| Injection, diphenhydramine hcl, up to 50 mg | 843 | $1 | $2 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 516 | $48 | $276 |
| Office visit, established patient (20-29 min) | 445 | $69 | $116 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 394 | $16 | $88 |
| Administration of chemotherapy into vein, 1 hour or less | 390 | $100 | $622 |
| Drug injection, under skin or into muscle | 186 | $11 | $84 |
| Administration of chemotherapy into vein, each additional hour | 171 | $22 | $141 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 86 | $43 | $160 |
| Injection of additional new drug or substance into vein | 70 | $12 | $95 |
| Administration of additional new drug or substance into vein, 1 hour or less | 59 | $50 | $303 |
| New patient office visit (45-59 min) | 50 | $106 | $302 |
| Administration of additional new drug or substance into vein using push technique | 45 | $43 | $255 |
| Advance care planning consultation, first 30 min | 33 | $57 | $225 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 31 | $1 | $4 |
| Transitional care management services for problem of high complexity | 14 | $156 | $195 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
The majority of payments (94%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Abbasi-Hafshejani is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), and consulting-driven industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Abbasi-Hafshejani experienced with iron infusion (feraheme)?
Does Dr. Abbasi-Hafshejani receive payments from pharmaceutical companies?
How do Dr. Abbasi-Hafshejani's costs compare to other hematology & oncologys in The Woodlands?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology